TECH Bio-Techne Corp - Common Stock
NASDAQ · Life Sciences Tools & Services · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 24, 2026
$72.40
· % 处于52周区间
· 高于低点
· 至高点
$43.2052周低点
$72.6952周高点
市值 (MRQ)
$11.30B
P/E (TTM)
62.4
EPS (TTM)
$1.16
收入 (TTM)
$1.22B
TECH 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$72.40
市值 (MRQ)
$11.30B
P/E (TTM)
62.4
EPS (TTM)
$1.16
收入 (TTM)
$1.22B
股息收益率
0.44%
ROE (TTM)
9.0%
52周区间
$43–$73
TECH 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2022年11月30日 | 4-for-1 | 正向 |
| 2000年12月4日 | 2-for-1 | 正向 |
| 1997年11月18日 | 2-for-1 | 正向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$1.22B2017-06-30 → 2026-06-30
EPS$1.162017-06-30 → 2026-06-30
自由现金流$263M2017-06-30 → 2026-06-30
净利率15.0%2017-06-30 → 2026-06-30
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | TECH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 62.45年均值 ≈67.9 | ≈67.9 | 35.8 | 估值过高 | |
| P/S (TTM) | 9.35年均值 ≈8.0 | ≈8.0 | 4.1 | 估值过高 | |
| 市净率 (MRQ) | 5.45年均值 ≈4.7 | ≈4.7 | 3.6 | 估值过高 | |
| 股价/自由现金流 (TTM) | 42.95年均值 ≈38.5 | ≈38.5 | · | · | |
| 市现率 (TTM) | 38.75年均值 ≈32.9 | ≈32.9 | 27.7 | 估值过高 | |
| 市净率（有形资产） (MRQ) | 6.35年均值 ≈15.9 | ≈15.9 | · | · | |
| PEG Ratio (市盈率增长比) | ≈10.5 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | TECH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 65.8%5年均值 ≈66.6% | ≈66.6% | 53.1% | 顶尖 | |
| 营业利润率 (TTM) | 20.7%5年均值 ≈20.0% | ≈20.0% | 9.2% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | 28.7%5年均值 ≈29.1% | ≈29.1% | 9.8% | 顶尖 | |
| 税前利润率 (TTM) | 19.8%5年均值 ≈20.2% | ≈20.2% | 5.9% | 顶尖 | |
| 净利润率 (TTM) | 15.0%5年均值 ≈17.0% | ≈17.0% | 2.4% | 顶尖 | |
| ROA (TTM) | 7.1%5年均值 ≈7.9% | ≈7.9% | -0.14% | 顶尖 | |
| ROE (TTM) | 9.0%5年均值 ≈10.6% | ≈10.6% | -0.40% | 顶尖 | |
| ROIC | 9.0%5年均值 ≈10.0% | ≈10.0% | 1.1% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | TECH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 4.55年均值 ≈4.0 | ≈4.0 | 2.5 | 流动性强 | |
| Quick Ratio (速动比率) | 2.95年均值 ≈2.6 | ≈2.6 | 1.0 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | TECH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -0.38%5年均值 ≈5.7% | ≈5.7% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 2.2%5年均值 ≈7.2% | ≈7.2% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 5.5% | · | · | · | |
| EPS YoY | 152.2%5年均值 ≈30.5% | ≈30.5% | · | · | |
| Net Income YoY (净利润同比增长) | 147.8%5年均值 ≈29.8% | ≈29.8% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | -13.0%5年均值 ≈-18.5% | ≈-18.5% | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率（5年）) | 5.9% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | -13.9%5年均值 ≈-8.9% | ≈-8.9% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率（5年）) | 5.3% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | TECH | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.55年均值 ≈0.5 | ≈0.5 | 0.5 | 弱 | |
| Inventory Turnover (库存周转率) | 2.25年均值 ≈2.4 | ≈2.4 | 2.2 | 弱 | |
| Receivables Turnover (应收账款周转率) | 5.75年均值 ≈5.6 | ≈5.6 | 5.7 | 持平 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$405.0K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
股息 收益率、派息率、股息历史、5年CAGR
股息收益率0.44%
派息率27.5%
年度化派息≈$0.32
5年股息复合年增长率 (CAGR)≈0.00%
| 除息日 | 金额 | 货币 | 收益率 |
|---|---|---|---|
| 八月 24, 2026 | $0.08 | USD | ≈0.44% |
| 五月 18, 2026 | $0.08 | USD | ≈0.72% |
| 二月 13, 2026 | $0.08 | USD | ≈0.53% |
| 十一月 17, 2025 | $0.08 | USD | ≈0.55% |
| 八月 18, 2025 | $0.08 | USD | ≈0.60% |
| 五月 19, 2025 | $0.08 | USD | ≈0.65% |
| 二月 14, 2025 | $0.08 | USD | ≈0.49% |
| 十一月 8, 2024 | $0.08 | USD | ≈0.42% |
| 八月 19, 2024 | $0.08 | USD | ≈0.43% |
| 五月 10, 2024 | $0.08 | USD | ≈0.40% |
| 二月 9, 2024 | $0.08 | USD | ≈0.47% |
| 十一月 9, 2023 | $0.08 | USD | ≈0.56% |
| 八月 17, 2023 | $0.08 | USD | ≈0.40% |
| 五月 12, 2023 | $0.08 | USD | ≈0.39% |
| 二月 10, 2023 | $0.08 | USD | ≈0.42% |
| 十一月 10, 2022 | $0.08 | USD | ≈0.38% |
| 八月 12, 2022 | $0.08 | USD | ≈0.34% |
| 五月 13, 2022 | $0.08 | USD | ≈0.35% |
| 二月 10, 2022 | $0.08 | USD | ≈0.30% |
| 十一月 10, 2021 | $0.08 | USD | ≈0.25% |
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
1.4%
下次报告
十一月 03, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | $0.52 | $0.53 | -1.8% | |
| 2026年3月31日 | $0.53 | $0.55 | -3.3% | |
| 2025年12月31日 | $0.46 | $0.44 | 4.0% | |
| 2025年9月30日 | $0.42 | $0.43 | -2.0% | |
| 2025年6月30日 | $0.53 | $0.51 | 4.1% | |
| 2025年3月31日 | $0.56 | $0.52 | 7.4% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B | $931M | $739M | $714M | $643M | $563M | $499M | $452M | |
| Cost of Revenue | $416M | $429M | $389M | $367M | $349M | $298M | $255M | $241M | $211M | $188M | $162M | $145M | |
| Gross Profit | $799M | $790M | $770M | $770M | $756M | $633M | $483M | $473M | $432M | $375M | $337M | $307M | |
| SG&A Expense | $452M | $589M | $466M | $378M | $373M | $325M | $261M | $264M | $241M | $200M | $141M | $119M | |
| Operating Expenses | $547M | $688M | $563M | $471M | $460M | $396M | $326M | $327M | $296M | $254M | $186M | $160M | |
| Operating Income | $252M | $102M | $207M | $299M | $297M | $237M | $157M | $147M | $136M | $121M | $151M | $147M | |
| Interest Expense | · | · | · | $11M | $11M | $14M | $19M | $22M | $10M | $7M | $2M | $2M | |
| Other Non-op | $-6M | $831.0K | $-9M | $48M | $15M | $-76M | $138M | $-14M | $-447.0K | $-2M | $-2M | $8M | |
| Pretax Income | $241M | $98M | $186M | $339M | $301M | $148M | $276M | $112M | $126M | $112M | $147M | $154M | |
| Income Tax | $59M | $25M | $18M | $53M | $38M | $9M | $47M | $16M | $-198.0K | $36M | $43M | $46M | |
| Net Income | $182M | $73M | $168M | $285M | $272M | $140M | $229M | $96M | $126M | $76M | $104M | $108M | |
| EPS (Basic) | $1.17 | $0.47 | $1.07 | $1.81 | $1.73 | $0.91 | $6.00 | $2.54 | $3.36 | $2.04 | $2.81 | $2.90 | |
| EPS (Diluted) | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $5.82 | $2.47 | $3.31 | $2.03 | $2.80 | $2.89 | |
| Shares (Basic) | 155,963,000 | 157,521,000 | 157,708,000 | 157,179,000 | 156,874,000 | 154,986,000 | 38,201,000 | 37,781,000 | 37,476,000 | 37,313,000 | 37,194,000 | 37,096,000 | |
| Shares (Diluted) | 157,009,000 | 159,717,000 | 160,774,000 | 161,855,000 | 164,114,000 | 161,932,000 | 39,401,000 | 38,892,000 | 38,055,000 | 37,500,000 | 37,326,000 | 37,231,000 | |
| EBITDA | $349M | $212M | $318M | $406M | $398M | $325M | $240M | $225M | $201M | $181M | $193M | $37M |
资产负债表
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $265M | $162M | $152M | $181M | $173M | $199M | $147M | $101M | $122M | $92M | $64M | $55M | |
| Short-term Investments | · | · | $1M | $24M | $74M | $32M | $124M | $65M | $60M | $66M | $32M | $56M | |
| Receivables | $217M | $207M | $241M | $218M | $195M | $145M | $123M | $137M | $120M | $117M | $93M | $70M | |
| Inventory | $196M | $189M | $180M | $172M | $141M | $117M | $103M | $91M | $86M | $86M | $57M | $50M | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | $13M | $8M | $5M | |
| Other Current Assets | $67M | $37M | $34M | $27M | $23M | $17M | $24M | $18M | $11M | $13M | $8M | $6M | |
| Current Assets | $744M | $608M | $617M | $621M | $606M | $511M | $521M | $413M | $398M | $348M | $254M | $248M | |
| PP&E (Net) | $232M | $246M | $251M | $226M | $223M | $208M | $177M | $154M | $145M | $135M | $132M | $130M | |
| PP&E (Gross) | $540M | $532M | $508M | $460M | $435M | $398M | $347M | $306M | $285M | $263M | $246M | $239M | |
| Accum. Depreciation | $308M | $286M | $257M | $234M | $211M | $190M | $170M | $152M | $139M | $128M | $114M | $109M | |
| Goodwill | $975M | $981M | $973M | $873M | $822M | $843M | $728M | $733M | $598M | $579M | $431M | $391M | |
| Intangibles | $303M | $366M | $507M | $535M | $532M | $616M | $517M | $579M | $446M | $452M | $311M | $293M | |
| Other Non-current Assets | $264M | $284M | $264M | $285M | $47M | $12M | $14M | $6M | $5M | $44M | $2M | $2M | |
| Total Assets | $2.59B | $2.56B | $2.70B | $2.64B | $2.29B | $2.26B | $2.03B | $1.88B | $1.59B | $1.56B | $1.13B | $1.06B | |
| Accounts Payable | $27M | $25M | $38M | $26M | $34M | $29M | $23M | $16M | $18M | $17M | $21M | $13M | |
| Accrued Liabilities | $20M | $26M | $25M | $15M | $18M | $15M | $9M | $26M | $20M | $19M | $8M | $7M | |
| Current Liabilities | $164M | $176M | $159M | $129M | $176M | $152M | $107M | $102M | $80M | $136M | $54M | $40M | |
| Capital Leases | $74M | $84M | $88M | $94M | $58M | $68M | $67M | $0 | · | · | · | · | |
| Deferred Tax | $19M | $6M | $56M | $89M | $99M | $93M | $101M | $90M | $86M | $121M | $63M | $61M | |
| Other Non-current Liabilities | $21M | $27M | $13M | $11M | $12M | $24M | $27M | $25M | $9M | $5M | $3M | $3M | |
| Total Debt | · | · | · | · | $12M | $12M | $12M | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $390.0K | $385.0K | $379.0K | $376.0K | $374.0K | $372.0K | $371.0K | |
| Retained Earnings | $1.14B | $1.07B | $1.33B | $1.31B | $1.12B | $1.09B | $1.06B | $932M | $877M | $799M | $771M | $714M | |
| AOCI | $-71M | $-60M | $-78M | $-66M | $-75M | $-57M | $-97M | $-84M | $-45M | $-49M | $-70M | $-31M | |
| Stockholders' Equity | $2.11B | $1.92B | $2.07B | $1.97B | $1.70B | $1.56B | $1.38B | $1.17B | $1.08B | $950M | $879M | $847M | |
| Liabilities + Equity | $2.59B | $2.56B | $2.70B | $2.64B | $2.29B | $2.26B | $2.03B | $1.88B | $1.59B | $1.56B | $1.13B | $1.06B | |
| Shares Outstanding | 156,095,113 | 154,972,196 | 158,216,000 | 157,642,000 | 156,644,000 | 155,822,000 | 153,812,000 | 37,934,000 | 37,608,000 | 37,356,000 | 37,254,000 | 37,153,000 |
现金流
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $97M | $110M | $112M | $107M | $101M | $88M | $83M | $78M | $64M | $60M | $43M | $37M | |
| Stock-based Comp | $41M | $41M | $38M | $39M | $42M | $49M | $32M | $32M | $28M | $15M | $9M | $6M | |
| Deferred Tax | $24M | $-51M | $-40M | $-30M | $7M | $-28M | $14M | $-14M | $-46M | $-5M | $-3M | $1M | |
| Amort. of Intangibles | $62M | $76M | $80M | $77M | $74M | $65M | $61M | $59M | $47M | $44M | $29M | · | |
| Restructuring | · | · | $12M | $4M | $2M | $142.0K | $87.0K | · | $376.0K | · | · | · | |
| Other Non-cash | $-52M | $115M | $21M | $-148M | $-97M | $103M | $-153M | $-11M | $-2M | $-4M | $-10M | $-13M | |
| Operating Cash Flow | $292M | $288M | $299M | $254M | $325M | $352M | $205M | $182M | $170M | $144M | $144M | $139M | |
| CapEx | $29M | $31M | $63M | $38M | $45M | $44M | $52M | $25M | $21M | $15M | $17M | $20M | |
| Investing Cash Flow | $-18M | $-35M | $-203M | $-266M | $-97M | $-244M | $27M | $-337M | $-39M | $-306M | $-108M | · | |
| Stock Repurchased | $42M | $276M | $80M | $20M | $161M | $43M | $50M | $15M | $0 | · | · | $0 | |
| Net Stock Activity | $-42M | $-276M | $-80M | $-20M | $-161M | $-43M | $-50M | $-15M | · | · | · | $0 | |
| Dividends Paid | $50M | $50M | $50M | $50M | $50M | $50M | $49M | $48M | $48M | $47M | $48M | $47M | |
| Financing Cash Flow | $-169M | $-254M | $-122M | $23M | $-243M | $-63M | $-184M | $134M | $-99M | $189M | $-23M | · | |
| Net Change in Cash | $103M | $10M | $-29M | $8M | $-27M | $52M | $46M | $-21M | $30M | $27M | $10M | $-264M | |
| Taxes Paid | $64M | $74M | $65M | $88M | $30M | $21M | $42M | $37M | $35M | $43M | $45M | $43M | |
| Free Cash Flow | $263M | $257M | $236M | $216M | $280M | $308M | $153M | $156M | $149M | $128M | $127M | $119M | |
| Levered FCF | · | · | · | $207M | $270M | $295M | $138M | $138M | $139M | $123M | $126M | $118M |
盈利能力
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% | 67.2% | 66.5% | 67.5% | 67.9% | |
| Operating Margin | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% | 25.5% | 21.3% | 20.5% | 21.2% | 21.4% | 30.2% | 0.03% | |
| Net Margin | 15.0% | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% | 19.6% | 13.5% | 20.9% | 23.8% | |
| Pretax Margin | 19.8% | 8.1% | 16.0% | 29.8% | 27.3% | 15.9% | 37.4% | 15.7% | 19.6% | 19.9% | 29.5% | 34.1% | |
| EBITDA Margin | 28.7% | 17.4% | 27.5% | 35.7% | 36.0% | 34.9% | 32.5% | 31.5% | 31.2% | 32.1% | 38.8% | 8.3% | |
| ROA | 7.1% | 2.8% | 6.3% | 11.6% | 11.9% | 6.6% | 11.7% | · | 8.0% | 5.7% | 9.5% | 11.2% | |
| ROE | 9.0% | 3.7% | 8.2% | 15.6% | 16.7% | 9.5% | 17.0% | · | 11.8% | 8.3% | 12.1% | 13.1% | |
| ROIC | 9.0% | 4.0% | 9.0% | 12.8% | 15.1% | 14.2% | 9.4% | · | 12.6% | 8.6% | 12.1% | 0.01% |
流动性与偿付能力
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 3.5 | 3.9 | 4.8 | 3.4 | 3.4 | 4.9 | · | 5.0 | 2.6 | 4.7 | 6.2 | |
| Quick Ratio | 2.9 | 2.1 | 2.5 | 3.3 | 2.1 | 2.5 | 3.7 | · | 3.8 | 2.0 | 3.5 | 4.6 | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | · | 26.7 | 26.2 | 17.0 | 8.2 | 6.8 | 13.4 | 16.4 | 86.2 | 0.1 |
效率
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.5 | 0.5 | |
| Inventory Turnover | 2.2 | 2.3 | 2.2 | 2.3 | 2.7 | 2.7 | 2.6 | · | 2.5 | 3.2 | 3.0 | 3.3 | |
| Receivables Turnover | 5.7 | 5.4 | 5.0 | 5.5 | 6.5 | 7.0 | 5.7 | · | 5.4 | 5.4 | 6.1 | 7.2 |
每股
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.51 | $12.38 | $13.08 | $12.47 | $43.46 | $40.12 | $35.92 | · | $28.69 | $25.42 | $23.60 | $22.80 | |
| Revenue / Share | $7.74 | $7.64 | $7.21 | $7.02 | $26.95 | $23.00 | $18.75 | $18.36 | $16.90 | $15.01 | $13.37 | $12.15 | |
| Cash Flow / Share | $1.86 | $1.80 | $1.86 | $1.57 | $7.93 | $8.70 | $5.21 | $4.67 | $4.48 | $3.83 | $3.85 | $3.74 | |
| Cash / Share | $1.70 | $1.05 | $0.96 | $1.15 | $4.41 | $5.11 | $3.81 | · | $3.24 | $2.45 | $1.72 | $1.47 | |
| Dividend / Share | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $1.28 | $1.28 | $1.28 | $1.28 | · | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | $1.28 | $1.28 | $1.28 | $1.27 | |
| EPS (TTM) | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $5.82 | $2.47 | $3.31 | $2.03 | $2.80 | $2.89 |
增长率
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.38% | 5.2% | 2.0% | 2.8% | 18.8% | 26.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.2% | 3.3% | 7.6% | 15.4% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.5% | 10.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 152.2% | -56.2% | -40.3% | 6.0% | 90.8% | -85.0% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | -34.8% | 6.5% | -32.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.9% | -39.8% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 147.8% | -56.3% | -41.1% | 4.9% | 93.8% | -38.8% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -13.9% | -35.4% | 6.2% | 7.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.3% | -20.4% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 0.12% | 0.60% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B | $931M | $739M | $714M | $643M | $563M | $499M | $452M | |
| Net Income TTM | $182M | $73M | $168M | $285M | $272M | $140M | $229M | $96M | $126M | $76M | $104M | $108M | |
| Market Cap | $11.03B | $7.97B | $11.34B | $12.87B | $3.39B | $4.39B | $2.54B | · | $1.39B | $1.10B | $1.05B | $915M | |
| Enterprise Value | · | · | · | · | $3.23B | $4.17B | $2.28B | · | · | · | · | · | |
| P/E | 60.9 | 111.8 | 68.2 | 46.4 | 52.2 | 129.4 | 11.3 | 21.1 | 11.2 | 14.5 | 10.1 | 8.5 | |
| P/S | 9.1 | 6.5 | 9.8 | 11.3 | 3.1 | 4.7 | 3.4 | · | 2.2 | 1.9 | 2.1 | 2.0 | |
| P/B | 5.2 | 4.2 | 5.5 | 6.5 | 2.0 | 2.8 | 1.8 | · | 1.3 | 1.2 | 1.2 | 1.1 | |
| P / Tangible Book | 13.3 | 13.9 | 19.2 | 23.0 | 9.8 | 42.2 | 18.6 | · | · | · | · | · | |
| P / Cash Flow | 37.8 | 27.7 | 37.9 | 50.6 | 10.4 | 12.5 | 12.4 | · | 8.2 | 7.6 | 7.3 | 6.6 | |
| P / FCF | 41.9 | 31.1 | 48.0 | 59.5 | 12.1 | 14.2 | 16.5 | · | 9.3 | 8.6 | 8.3 | 7.7 | |
| EV / EBITDA | · | · | · | · | 8.1 | 12.8 | 9.5 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | 11.5 | 13.5 | 14.9 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | 2.9 | 4.5 | 3.1 | · | · | · | · | · | |
| Dividend Yield | 0.45% | 0.63% | 0.44% | 0.39% | 1.5% | 1.1% | 1.9% | · | 3.5% | 4.3% | 4.5% | 5.1% | |
| Earnings Yield | 1.6% | 0.89% | 1.5% | 2.2% | 1.9% | 0.77% | 8.8% | 4.7% | 8.9% | 6.9% | 9.9% | 11.7% | |
| Payout Ratio | 27.5% | 68.7% | 30.0% | 17.6% | 18.4% | 35.3% | 21.3% | 50.3% | 38.0% | 62.2% | 45.6% | 43.7% | |
| Annual Payout | $50M | $50M | $50M | $50M | $50M | $50M | $49M | $48M | $48M | $47M | $48M | $47M |
损益表
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321M | $311M | $296M | $287M | $317M | $316M | $297M | $289M | $306M | $303M | $273M | $277M | $301M | $294M | $272M | $270M | |
| Cost of Revenue | $110M | $103M | $105M | $98M | $118M | $102M | $103M | $106M | $103M | $99M | $96M | $92M | $97M | $92M | $88M | $90M | |
| Gross Profit | $211M | $208M | $191M | $188M | $199M | $215M | $194M | $183M | $203M | $205M | $177M | $185M | $205M | $202M | $183M | $180M | |
| SG&A Expense | $113M | $109M | $114M | $116M | $197M | $151M | $121M | $119M | $134M | $112M | $116M | $105M | $87M | $99M | $93M | $99M | |
| Operating Expenses | $137M | $133M | $137M | $140M | $223M | $176M | $146M | $143M | $158M | $138M | $139M | $129M | $110M | $122M | $115M | $123M | |
| Operating Income | $74M | $75M | $54M | $48M | $-24M | $39M | $47M | $40M | $46M | $67M | $38M | $56M | $95M | $80M | $68M | $56M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | $4M | $5M | · | $1M | $2M | $4M | |
| Other Non-op | $2M | $-4M | $-4M | $333.0K | $6M | $-434.0K | $-5M | $184.0K | $8M | $-6M | $-5M | $-6M | $2M | $-15.0K | $-1M | $47M | |
| Pretax Income | $71M | $71M | $51M | $48M | $-23M | $38M | $43M | $40M | $42M | $61M | $33M | $50M | $88M | $80M | $66M | $104M | |
| Income Tax | $16M | $20M | $13M | $10M | $-5M | $16M | $8M | $7M | $1M | $12M | $6M | $-1M | $13M | $10M | $16M | $14M | |
| Net Income | $55M | $51M | $38M | $38M | $-18M | $23M | $35M | $34M | $41M | $49M | $27M | $51M | $75M | $70M | $50M | $90M | |
| EPS (Basic) | $0.35 | $0.33 | $0.24 | $0.25 | $-0.10 | $0.14 | $0.22 | $0.21 | $0.27 | $0.31 | $0.17 | $0.32 | $0.47 | $0.45 | $0.32 | $0.57 | |
| EPS (Diluted) | $0.36 | $0.32 | $0.24 | $0.24 | $-0.11 | $0.14 | $0.22 | $0.21 | $0.26 | $0.31 | $0.17 | $0.31 | $0.47 | $0.43 | $0.31 | $0.55 | |
| Shares (Basic) | · | 156,327,000 | 155,839,000 | 155,464,000 | · | 157,372,000 | 158,431,000 | 158,531,000 | · | 157,309,000 | 157,533,000 | 158,130,000 | · | 157,311,000 | 157,011,000 | 156,929,000 | |
| Shares (Diluted) | · | 157,403,000 | 156,999,000 | 156,362,000 | · | 158,944,000 | 160,626,000 | 161,115,000 | · | 160,496,000 | 160,060,000 | 161,940,000 | · | 161,615,000 | 161,750,000 | 162,172,000 | |
| EBITDA | · | $75M | $54M | $72M | · | $39M | $47M | $68M | · | $67M | $38M | $84M | · | $80M | $68M | $83M |
资产负债表
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $265M | $210M | $173M | $145M | $162M | $141M | $178M | $188M | $152M | $140M | $130M | $149M | · | $127M | $165M | $165M | |
| Short-term Investments | · | · | · | · | · | $0 | $0 | · | $1M | $5M | $6M | · | · | $30M | $32M | $38M | |
| Receivables | $217M | $215M | $185M | $184M | $207M | $237M | $218M | $224M | $241M | $228M | $207M | $205M | · | $216M | $185M | $174M | |
| Inventory | $196M | $201M | $205M | $203M | $189M | $191M | $188M | $185M | $180M | $179M | $181M | $186M | · | $169M | $160M | $150M | |
| Other Current Assets | $67M | $62M | $74M | $77M | $37M | $54M | $50M | $43M | $34M | $31M | $40M | $52M | · | $28M | $23M | $25M | |
| Current Assets | $744M | $688M | $637M | $610M | $608M | $627M | $635M | $649M | $617M | $611M | $591M | $591M | · | $571M | $565M | $552M | |
| PP&E (Net) | $232M | $233M | $234M | $240M | $246M | $252M | $250M | $254M | $251M | $244M | $234M | $232M | · | $224M | $224M | $224M | |
| PP&E (Gross) | $540M | $534M | $527M | $529M | $532M | $531M | $520M | $519M | $508M | $496M | $479M | $473M | · | $454M | $447M | $440M | |
| Accum. Depreciation | $308M | $301M | $293M | $289M | $286M | $279M | $270M | $265M | $257M | $252M | $245M | $241M | · | $230M | $223M | $216M | |
| Goodwill | $975M | $978M | $981M | $979M | $981M | $969M | $965M | $983M | $973M | $971M | $980M | $969M | $873M | $871M | $870M | $865M | |
| Intangibles | $303M | $319M | $335M | $350M | $366M | $444M | $461M | $486M | $507M | $526M | $551M | $579M | $535M | $553M | $568M | $586M | |
| Other Non-current Assets | $264M | $264M | $267M | $277M | $284M | $269M | $275M | $276M | $264M | $272M | $274M | $282M | · | $283M | $53M | $54M | |
| Total Assets | $2.59B | $2.55B | $2.52B | $2.53B | $2.56B | $2.64B | $2.67B | $2.74B | $2.70B | $2.72B | $2.73B | $2.76B | · | $2.60B | $2.36B | $2.35B | |
| Accounts Payable | $27M | $23M | $26M | $30M | $25M | $32M | $33M | $32M | $38M | $29M | $32M | $28M | · | $27M | $24M | $30M | |
| Accrued Liabilities | $20M | $18M | $20M | $19M | $26M | $24M | $28M | $21M | $25M | $18M | $17M | $16M | · | $16M | $16M | $14M | |
| Current Liabilities | $164M | $153M | $140M | $145M | $176M | $169M | $161M | $142M | $159M | $150M | $135M | $128M | · | $141M | $128M | $138M | |
| Capital Leases | $74M | $76M | $77M | $81M | $84M | $79M | $82M | $85M | $88M | $93M | $96M | $97M | · | $93M | $78M | $65M | |
| Deferred Tax | $19M | $14M | $11M | $11M | $6M | $32M | $38M | $50M | $56M | $64M | $72M | $83M | · | $95M | $111M | $113M | |
| Other Non-current Liabilities | $21M | $22M | $23M | $24M | $27M | $16M | $11M | $20M | $13M | $12M | $17M | $9M | · | $11M | $11M | $12M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $392.0K | |
| Retained Earnings | $1.14B | $1.15B | $1.11B | $1.08B | $1.07B | $1.20B | $1.29B | $1.34B | $1.33B | $1.30B | $1.26B | $1.33B | · | $1.25B | $1.20B | $1.16B | |
| AOCI | $-71M | $-67M | $-62M | $-64M | $-60M | $-82M | $-86M | $-60M | $-78M | $-75M | $-64M | $-78M | · | $-74M | $-75M | $-92M | |
| Stockholders' Equity | $2.11B | $2.09B | $2.01B | $1.97B | $1.92B | $2.02B | $2.08B | $2.14B | $2.07B | $2.01B | $1.96B | $2.00B | $1.97B | $1.89B | $1.83B | $1.75B | |
| Liabilities + Equity | $2.59B | $2.55B | $2.52B | $2.53B | $2.56B | $2.64B | $2.67B | $2.74B | $2.70B | $2.72B | $2.73B | $2.76B | · | $2.60B | $2.36B | $2.35B | |
| Shares Outstanding | 156,095,113 | 156,516,091 | 155,881,291 | 155,749,477 | 154,972,196 | 156,760,717 | 157,915,999 | 158,878,127 | 158,216,000 | 157,554,366 | 157,142,004 | 158,354,579 | 157,642,000 | 157,339,318 | 157,093,879 | 39,232,094 |
现金流
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $25M | $24M | $27M | $28M | $27M | $28M | $28M | $27M | $28M | $29M | $27M | $27M | $27M | $27M | |
| Stock-based Comp | $5M | $10M | $14M | $12M | $5M | $11M | $15M | $10M | $7M | $8M | $13M | $10M | $-2M | $10M | $17M | $14M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $4M | · | · | · | $4M | |
| Amort. of Intangibles | $15M | $16M | $16M | $15M | $18M | $19M | $19M | $20M | $20M | $20M | $20M | $20M | · | $20M | $19M | $20M | |
| Restructuring | · | · | · | · | · | · | · | · | $21M | $1M | $11M | · | · | · | · | · | |
| Other Non-cash | · | · | · | $-47M | · | · | · | $-8M | · | · | · | $-34M | · | · | · | $-75M | |
| Operating Cash Flow | $95M | $87M | $82M | $28M | $98M | $41M | $84M | $64M | $75M | $81M | $83M | $59M | $83M | $51M | $64M | $56M | |
| CapEx | $8M | $9M | $6M | $5M | $5M | $10M | $7M | $9M | $18M | $16M | $15M | $14M | $11M | $12M | $6M | $10M | |
| Investing Cash Flow | $-7M | $-6M | $-6M | $605.0K | $406.0K | $-9M | $-5M | $-22M | $-9M | $-16M | $-24M | $-154M | $-5M | $-241M | $-109.0K | $-20M | |
| Stock Repurchased | $42M | $0 | $0 | $24.0K | $100M | $100M | · | · | $0 | $0 | · | · | $0 | $0 | $0 | $20M | |
| Net Stock Activity | · | · | · | $-24.0K | · | · | · | · | · | · | · | · | · | · | · | $-20M | |
| Dividends Paid | $12M | $13M | $12M | $12M | $12M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | |
| Financing Cash Flow | $-33M | $-43M | $-49M | $-44M | $-90M | $-68M | $-84M | $-12M | $-60M | $-52M | $-81M | $72M | $-24M | $151M | $-72M | $-32M | |
| Net Change in Cash | $55M | $37M | $28M | $-17M | $22M | $-37M | $-10M | $36M | $12M | $10M | $-19M | $-32M | $53M | $-37M | $-575.0K | $-7M | |
| Free Cash Flow | · | · | · | $22M | · | · | · | $55M | · | · | · | $46M | · | · | · | $47M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $41M | · | · | · | $43M |
盈利能力
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 66.9% | 64.6% | 65.6% | · | 67.9% | 65.3% | 63.2% | · | 67.4% | 64.8% | 66.9% | · | 68.7% | 67.5% | 66.6% | |
| Operating Margin | · | 24.2% | 18.4% | 16.6% | · | 12.2% | 16.0% | 13.8% | · | 22.1% | 13.9% | 20.2% | · | 27.3% | 25.0% | 20.9% | |
| Net Margin | · | 16.4% | 12.8% | 13.3% | · | 7.1% | 11.8% | 11.6% | · | 16.2% | 10.1% | 18.4% | · | 23.9% | 18.4% | 33.2% | |
| Pretax Margin | · | 22.9% | 17.2% | 16.8% | · | 12.1% | 14.4% | 13.9% | · | 20.1% | 12.2% | 17.9% | · | 27.3% | 24.5% | 38.5% | |
| EBITDA Margin | · | 24.2% | 18.4% | 25.1% | · | 12.2% | 16.0% | 23.5% | · | 22.1% | 13.9% | 30.5% | · | 27.3% | 25.0% | 30.8% | |
| ROA | · | 2.0% | 1.5% | 1.5% | · | 0.84% | 1.3% | 1.2% | · | 1.8% | 1.1% | 2.0% | · | 2.9% | 2.1% | 3.9% | |
| ROE | · | 2.5% | 1.9% | 1.9% | · | 1.1% | 1.7% | 1.6% | · | 2.5% | 1.5% | 2.7% | · | 3.9% | 2.8% | 5.3% | |
| ROIC | · | 2.6% | 2.0% | 1.9% | · | 1.1% | 1.9% | 1.6% | · | 2.7% | 1.6% | 2.9% | · | 3.7% | 2.8% | 2.8% |
流动性与偿付能力
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.5 | 4.5 | 4.2 | · | 3.7 | 3.9 | 4.6 | · | 4.1 | 4.4 | 4.6 | · | 4.0 | 4.4 | 4.0 | |
| Quick Ratio | · | 2.8 | 2.5 | 2.3 | · | 2.2 | 2.5 | 2.9 | · | 2.5 | 2.5 | 2.8 | · | 2.6 | 3.0 | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 16.7 | 8.8 | 11.4 | · | 58.7 | 28.8 | 14.9 |
效率
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Inventory Turnover | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.7 | |
| Receivables Turnover | · | 1.4 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.5 | · | 1.4 | 1.6 | 1.7 |
每股
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $13.32 | $12.90 | $12.62 | · | $12.87 | $13.16 | $13.46 | · | $12.79 | $12.50 | $12.62 | · | $12.01 | $11.63 | $44.64 | |
| Revenue / Share | · | $1.98 | $1.88 | $1.83 | · | $1.99 | $1.85 | $1.80 | · | $1.89 | $1.70 | $1.71 | · | $1.82 | $1.68 | $6.65 | |
| Cash Flow / Share | · | · | · | $0.18 | · | · | · | $0.40 | · | · | · | $0.37 | · | · | · | $1.38 | |
| Cash / Share | · | $1.34 | $1.11 | $0.93 | · | $0.90 | $1.12 | $1.18 | · | $0.89 | $0.83 | $0.94 | · | $0.81 | $1.05 | $4.21 | |
| Dividend / Share | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | $-0.16 | $0.24 | $0.16 | $0.08 | |
| EPS (TTM) | · | $0.69 | $0.51 | $0.49 | · | $0.83 | $1.00 | $0.95 | · | $1.26 | $1.38 | $1.52 | · | $0.40 | $0.34 | $0.52 |
估值 (TTM)
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1.21B | $1.22B | $1.22B | · | $1.21B | $1.20B | $1.17B | · | $1.15B | $1.14B | $1.14B | · | $1.12B | $1.12B | $1.12B | |
| Net Income TTM | · | $110M | $81M | $78M | · | $132M | $158M | $151M | · | $203M | $224M | $247M | · | $271M | $262M | $292M | |
| Market Cap | · | $8.18B | $9.17B | $8.66B | · | $9.19B | $11.37B | $12.70B | · | $11.09B | $12.13B | $10.78B | · | $11.67B | $13.02B | $2.79B | |
| P/E | · | 75.7 | 115.3 | 113.5 | · | 70.6 | 72.0 | 84.1 | · | 55.9 | 55.9 | 44.8 | · | 185.5 | 243.8 | 136.5 | |
| P/S | · | 6.8 | 7.5 | 7.1 | · | 7.6 | 9.5 | 10.8 | · | 9.6 | 10.6 | 9.4 | · | 10.4 | 11.6 | 2.5 | |
| P/B | · | 3.9 | 4.6 | 4.4 | · | 4.6 | 5.5 | 5.9 | · | 5.5 | 6.2 | 5.4 | · | 6.2 | 7.1 | 1.6 | |
| P / Tangible Book | · | 10.4 | 13.2 | 13.6 | · | 15.2 | 17.4 | 19.0 | · | 21.5 | 28.0 | 24.0 | · | 25.1 | 33.4 | 9.3 | |
| P / Cash Flow | · | · | · | 314.1 | · | · | · | 198.8 | · | · | · | 181.5 | · | · | · | 49.7 | |
| Dividend Yield | · | 0.61% | 0.54% | 0.58% | · | 0.55% | 0.45% | 0.40% | · | 0.45% | 0.42% | 0.47% | · | 0.43% | 0.39% | 1.8% | |
| Earnings Yield | · | 1.3% | 0.87% | 0.88% | · | 1.4% | 1.4% | 1.2% | · | 1.8% | 1.8% | 2.2% | · | 0.54% | 0.41% | 0.73% | |
| Payout Ratio | · | · | · | 32.6% | · | · | · | 37.8% | · | · | · | 24.8% | · | · | · | 14.0% | |
| Annual Payout | · | $50M | $50M | $50M | · | $51M | $51M | $50M | · | $50M | $50M | $50M | · | $50M | $50M | $50M |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 收入 | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B |
| 毛利率 % | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% |
| 营业利润率 % | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% |
| 净收入 | $182M | $73M | $168M | $285M | $272M |
| 稀释后每股收益 (EPS) | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 |
| 指标 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | · | · | · | · | 0.0 |
| 流动比率 | 4.5 | 3.5 | 3.9 | 4.8 | 3.4 |
| 速动比率 | 2.9 | 2.1 | 2.5 | 3.3 | 2.1 |
| 指标 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 自由现金流 | $263M | $257M | $236M | $216M | $280M |
机构持有人 (13F) 635 家申报者 · $13.4B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
635
持有价值
$13.4B
新仓位
131
已退出持仓
110
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 131 (+46 与上一季度对比) | 110 (+52 与上一季度对比) | 159 (-43 与上一季度对比) | 248 (+27 与上一季度对比) | +3.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1047457735 | 17810878 | 7.84% | 股份 |
| BlackRock, Inc. | $990923913 | 14025816 | 7.42% | 股份 |
| FMR LLC | $903951465 | 12794784 | 6.77% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $721941123 | 10218558 | 5.40% | 股份 |
| GOLDMAN SACHS GROUP INC | $518805868 | 7343324 | 3.88% | 股份 |
| HBK INVESTMENTS L P | $482186250 | 6825000 | 3.61% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $459674334 | 6506360 | 3.44% | 股份 |
| MORGAN STANLEY | $450374056 | 6374717 | 3.37% | 股份 |
| STATE STREET CORP | $422513141 | 5980370 | 3.16% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $377544673 | 5351464 | 2.83% | 股份 |
| Invesco Ltd. | $352290855 | 4986424 | 2.64% | 股份 |
| Ruane, Cunniff & Goldfarb L.P. | $236595617 | 3348841 | 1.77% | 股份 |
| SNYDER CAPITAL MANAGEMENT L P | $223523600 | 3163816 | 1.67% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $200977476 | 2844692 | 1.50% | 股份 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $194007331 | 2746462 | 1.45% | 股份 |
| MAIRS & POWER INC | $190804299 | 2700698 | 1.43% | 股份 |
| Capital Research Global Investors | $185236529 | 2621890 | 1.39% | 股份 |
| UBS Group AG | $175113585 | 2478607 | 1.31% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $159216156 | 2253512 | 1.19% | 股份 |
| WHITEBOX ADVISORS LLC | $148365071 | 2100001 | 1.11% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $146056441 | 2067324 | 1.09% | 股份 |
| JPMORGAN CHASE & CO | $132595073 | 1862805 | 0.99% | 股份 |
| Amundi | $129094567 | 1827241 | 0.97% | 股份 |
| RGM Capital, LLC | $126562178 | 2152052 | 0.95% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $114623691 | 1622416 | 0.86% | 股份 |
| MAVERICK CAPITAL LTD | $108490847 | 1535610 | 0.81% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $104625879 | 2002026 | 0.78% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $100035859 | 1410943 | 0.75% | 股份 |
| NORGES BANK | $99873595 | 1413639 | 0.75% | 股份 |
| FIRST TRUST ADVISORS LP | $97062653 | 1373852 | 0.73% | 股份 |
| NORTHERN TRUST CORP | $92635432 | 1311188 | 0.69% | 股份 |
| BROWN ADVISORY INC | $90965942 | 1287558 | 0.68% | 股份 |
| Bank of New York Mellon Corp | $90304574 | 1278196 | 0.68% | 股份 |
| Madison Asset Management, LLC | $75134377 | 1063473 | 0.56% | 股份 |
| GENEVA CAPITAL MANAGEMENT LLC | $71503266 | 1012077 | 0.54% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $69875181 | 989033 | 0.52% | 股份 |
| AMERICAN CAPITAL MANAGEMENT INC | $68798193 | 973789 | 0.51% | 股份 |
| CITADEL ADVISORS LLC | $68242106 | 965918 | 0.51% | 股份 |
| BANK OF AMERICA CORP /DE/ | $67487527 | 955237 | 0.51% | 股份 |
| Stephens Investment Management Group LLC | $66742843 | 944697 | 0.50% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $66643227 | 943287 | 0.50% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $62118094 | 879237 | 0.46% | 股份 |
| TIG Advisors, LLC | $59500865 | 842192 | 0.45% | 股份 |
| Balyasny Asset Management L.P. | $59124866 | 836870 | 0.44% | 股份 |
| JONES FINANCIAL COMPANIES LLLP | $56587061 | 797001 | 0.42% | 股份 |
| ROYCE & ASSOCIATES LP | $55795484 | 789745 | 0.42% | 股份 |
| CRAMER ROSENTHAL MCGLYNN LLC | $54734180 | 774723 | 0.41% | 股份 |
| Magnetar Financial LLC | $53829012 | 761911 | 0.40% | 股份 |
| AQR Arbitrage LLC | $53825974 | 761868 | 0.40% | 股份 |
| Cresset Asset Management, LLC | $52048420 | 736708 | 0.39% | 股份 |
公司内部人士 35 位内幕人士 · 17 位高管 · 20 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Kim Kelderman | Chief Executive Officer | 2026年8月17日 A | 82762 | 0 | 0 | $0 |
| Charles R. Kummeth | Chief Executive Officer | 2023年8月15日 A | 1278269 | 0 | 0 | $0 |
| Thomas E Oland | CEO, President | 2011年11月30日 G | 1177420 | 0 | 0 | $0 |
| James Hippel | CFO | 2026年8月17日 A | 170183 | 0 | 0 | $0 |
| Gregory J Melsen | CFO | 2013年8月1日 A | 1438 | 0 | 0 | $0 |
| Steven C. Crouse | President - Diag & Spatial Bi | 2026年8月17日 A | 10237 | 0 | 0 | $0 |
| William Geist | PRESIDENT, PROTEIN SCIENCES | 2026年8月17日 A | 24943 | 0 | 0 | $0 |
| Matthew Mcmanus | President - Diag & Spatial Bio | 2026年2月1日 M | 7691 | 0 | 0 | $0 |
| Norman David Eansor | President-Protein Sciences | 2021年11月16日 M | 2117 | 0 | 0 | $0 |
| Shane Bohnen | SVP - General Counsel | 2026年8月17日 A | 10360 | 0 | 0 | $0 |
| Brenda S. Furlow | SVP - GENERAL COUNSEL | 2022年12月8日 M | 26092 | 0 | 0 | $0 |
| Kevin S Gould | SVP Clinical Controls | 2017年10月26日 A | 1355 | 0 | 0 | $0 |
| Robert M. Gavin | Sen. VP Protein Platforms | 2017年10月26日 A | 1667 | 0 | 0 | $0 |
| Fernando J. Bazan | Chief Technical Officer | 2017年10月26日 A | · | 0 | 0 | $0 |
| Marcel Veronneau | SVP - Clinical Controls | 2015年8月7日 A | 34989 | 0 | 0 | $0 |
| Kevin J Reagan | Senior VP - Biotech | 2014年12月9日 M | 0 | 0 | 0 | $0 |
| Monica Tsang | VP of Research | 2007年5月3日 S | 0 | 0 | 0 | $0 |
| John L Higgins | 董事 | 2026年9月28日 M | 77254 | 0 | 0 | $0 |
| Robert V Baumgartner | 董事 | 2026年9月22日 M | 56884 | 0 | 0 | $0 |
| Amy E. Herr | 董事 | 2026年8月17日 A | 576 | 0 | 2 | $-437168 |
| Judith V. Klimovsky | 董事 | 2025年10月30日 A | 3782 | 0 | 0 | $0 |
| Alpna Seth | 董事 | 2025年10月30日 A | 15411 | 0 | 0 | $0 |
| Rupert Vessey | 董事 | 2025年10月30日 A | 10987 | 0 | 0 | $0 |
| Julie L Bushman | 董事 | 2025年10月30日 A | 8775 | 0 | 0 | $0 |
| Joseph D Keegan | 董事 | 2025年10月30日 A | 15411 | 0 | 0 | $0 |
| Roeland Nusse | 董事 | 2025年8月25日 M | 44559 | 0 | 0 | $0 |
| Randolph C Steer | 董事 | 2023年10月26日 A | 24201 | 0 | 0 | $0 |
| Harold J Wiens | 董事 | 2020年5月29日 M | 4843 | 0 | 0 | $0 |
| Charles A Dinarello | 董事 | 2018年8月8日 M | 8212 | 0 | 0 | $0 |
| Roger C Lucas | 董事 | 2017年10月10日 S | 1870 | 0 | 0 | $0 |
| Karen A Holbrook | 董事 | 2017年9月6日 S | 914 | 0 | 0 | $0 |
| Howard V Oconnell | 董事 | 2015年2月19日 M | 70000 | 0 | 0 | $0 |
| G A Herbert | 董事 | 2008年10月23日 A | 0 | 0 | 0 | $0 |
| Christopher S Henney | 董事 | 2004年9月17日 M | 0 | 0 | 0 | $0 |
| James A Weatherbee | · | 2004年8月11日 M | 66292 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 79 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1.65% | 199098 SH | 2026年10月2日 | 每日 |
| CVAR · ETF Opportunities Trust | 1.46% | 8709 NS | 2026年7月31日 | N-PORT |
| SMCO · Tidal Trust II | 1.23% | 24154 NS | 2026年7月31日 | N-PORT |
| ALTL · Pacer Funds Trust | 1.18% | 15133 NS | 2026年7月31日 | N-PORT |
| MNA · New York Life Investments ETF Trust | 0.96% | 33399 NS | 2026年7月31日 | N-PORT |
| IBB · iShares Trust | 0.83% | 1192234 SH | 2026年9月11日 | 每日 |
| HIBL · Direxion Shares ETF Trust | 0.80% | 8362 NS | 2026年7月31日 | N-PORT |
| PALC · Pacer Funds Trust | 0.72% | 21025 NS | 2026年7月31日 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.44% | 20095 NS | 2026年7月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.33% | 122557 SH | 2026年10月2日 | 每日 |
| BKMC · BNY Mellon ETF Trust | 0.30% | 26966 NS | 2026年7月31日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.30% | 2074464 SH | 2026年8月19日 | 每日 |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.25% | 69377 NS | 2026年7月31日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.23% | 78263 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.22% | 28839 SH | 2026年9月11日 | 每日 |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 2701439 SH | 2026年10月2日 | 每日 |
| ESML · iShares Trust | 0.20% | 77713 SH | 2026年9月11日 | 每日 |
| IYH · iShares Trust | 0.18% | 91322 SH | 2026年9月11日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.16% | 74551 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.16% | 470400 SH | 2026年8月19日 | 每日 |
| JQUA · J.P. Morgan Exchange-Traded Fund ... | 0.16% | 179955 NS | 2026年7月31日 | N-PORT |
| SMMD · iShares Trust | 0.16% | 83492 SH | 2026年9月11日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.15% | 326736 NS | 2026年7月31日 | N-PORT |
| IXJ · iShares Trust | 0.14% | 82099 SH | 2026年9月11日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.13% | 3592334 SH | 2026年8月19日 | 每日 |
| CURE · Direxion Shares ETF Trust | 0.13% | 3081 NS | 2026年7月31日 | N-PORT |
| IWS · iShares Trust | 0.11% | 233699 SH | 2026年9月11日 | 每日 |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0.11% | 283124 SH | 2026年10月2日 | 每日 |
| WSML · iShares Trust | 0.11% | 9898 SH | 2026年9月11日 | 每日 |
| EQAL · Invesco Exchange-Traded Fund Trus... | 0.10% | 10488 SH | 2026年10月2日 | 每日 |
| IWR · iShares Trust | 0.08% | 642446 SH | 2026年9月11日 | 每日 |
| XOEF · iShares Trust | 0.07% | 201 SH | 2026年9月11日 | 每日 |
| JPME · J.P. Morgan Exchange-Traded Fund ... | 0.06% | 3597 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.05% | 328954 NS | 2026年7月31日 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Inde... | 0.05% | 31829 SH | 2026年10月2日 | 每日 |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.04% | 36220 SH | 2026年8月19日 | 每日 |
| IVE · iShares Trust | 0.04% | 260926 SH | 2026年9月11日 | 每日 |
| DFSU · Dimensional ETF Trust | 0.04% | 11899 NS | 2026年7月31日 | N-PORT |
| IUSV · iShares Trust | 0.04% | 139638 SH | 2026年9月11日 | 每日 |
| CHRI · Global X Funds | 0.03% | 38 NS | 2026年7月31日 | N-PORT |
| DSI · iShares Trust | 0.03% | 24046 SH | 2026年9月11日 | 每日 |
| IWD · iShares Trust | 0.03% | 347001 SH | 2026年9月11日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 94334 SH | 2026年8月19日 | 每日 |
| DCOR · Dimensional ETF Trust | 0.03% | 13560 NS | 2026年7月31日 | N-PORT |
| EGLE · Global X Funds | 0.03% | 8 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.02% | 6952 NS | 2026年7月31日 | N-PORT |
| XTR · Global X Funds | 0.02% | 14 NS | 2026年7月31日 | N-PORT |
| TOPC · iShares Trust | 0.02% | 94 SH | 2026年9月11日 | 每日 |
| XYLG · Global X Funds | 0.02% | 183 NS | 2026年7月31日 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.02% | 4066636 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 4969805 SH | 2026年8月19日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 26036 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 13051 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.02% | 35342 SH | 2026年8月19日 | 每日 |
| XVV · iShares Trust | 0.02% | 1844 SH | 2026年9月11日 | 每日 |
| XCLR · Global X Funds | 0.02% | 9 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.02% | 30368 NS | 2026年7月31日 | N-PORT |
| XYLD · Global X Funds | 0.02% | 7913 NS | 2026年7月31日 | N-PORT |
| PTLC · Pacer Funds Trust | 0.02% | 7907 NS | 2026年7月31日 | N-PORT |
| IVV · iShares Trust | 0.02% | 1980406 SH | 2026年9月11日 | 每日 |
| PBP · Invesco Exchange-Traded Fund Trust | 0.02% | 929 SH | 2026年10月2日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.02% | 48802 NS | 2026年7月31日 | N-PORT |
| IYY · iShares Trust | 0.02% | 6868 SH | 2026年9月11日 | 每日 |
| IWB · iShares Trust | 0.02% | 110265 SH | 2026年9月11日 | 每日 |
| SPUU · Direxion Shares ETF Trust | 0.02% | 591 NS | 2026年7月31日 | N-PORT |
| QDPL · Pacer Funds Trust | 0.02% | 3773 NS | 2026年7月31日 | N-PORT |
| XRMI · Global X Funds | 0.02% | 110 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.02% | 205546 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.02% | 43086 SH | 2026年9月10日 | 每日 |
| PHDG · Invesco Actively Managed Exchange... | 0.01% | 124 SH | 2026年9月29日 | 每日 |
| QVML · Invesco Exchange-Traded Fund Trus... | 0.01% | 3300 SH | 2026年10月2日 | 每日 |
| HCMT · Direxion Shares ETF Trust | 0.01% | 1089 NS | 2026年7月31日 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.01% | 12240 NS | 2026年7月31日 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.01% | 129171 SH | 2026年8月19日 | 每日 |
| DFUV · Dimensional ETF Trust | 0.01% | 21082 NS | 2026年7月31日 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trus... | 0.01% | 8378 SH | 2026年10月2日 | 每日 |
| ISCB · iShares Trust | · | 7135 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 14917 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 49071 SH | 2026年9月11日 | 每日 |
TECH 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 22 位分析师
持有
中位数目标
$73.00
+0.8%
3 13.6%
强烈买入
4 18.2%
买入
15 68.2%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
10 位分析师 · 2026-10-04平均目标 $70.50 -2.6%
现在
当前价格 $72.40
最低$50.00
平均值$70.50
最高$73.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| TECH | $11.03B | 60.9 | -0.38% | 15.0% | 9.0% | 65.8% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| BIO | · | · | · | · | · | · |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
最新新闻 提及该公司的近期头条新闻
Bio-Techne Takes Over #477 Spot From Charles River Laboratories International
Nasdaq · 3 月 前
Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal
Yahoo Finance · 3 月，1 周 前
Bio-Techne (TECH) Soars 20% on Merck $11.3B Merger
Yahoo Finance · 3 月，1 周 前
Germany’s Merck to Acquire Bio-Techne in $11.3 Billion Deal
Yahoo Finance · 3 月，1 周 前
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-K 于 八月 24, 2026 申报